The Biolocity Oversight Committee serves as both an advisory council and decision-making board to select funded projects. The committee consists of clinical, industry, regulatory, investment, and entrepreneurial veterans with relevant technology and medical expertise, along with partner university technology transfer advisers.

Mary Albertson, CLP, RTTP
Director of Technology Licensing at Georgia Tech Research Corporation

Kirk Barnes, BA
Co-Founder and President of Start-Up Commercialization and Sales Training of TransPharMed

Ibraheem Badejo, PhD
Senior R&D Director, Ethicon External Front End Innovation at Johnson & Johnson

Mark Boden, PhD
Senior Fellow/Technology Scout, Boston Scientific Corporation

Monte Eaves, MD
Director, American Board of Plastic Surgery and Founder & CEO, Brijjit Co, LLC

Andrés J. García, PhD
Executive Director, Parker H. Petit Institute for Bioengineering and Bioscience

Lee Herron, DVM
Vice President of Commercialization, Georgia Research Alliance

Michelle Ho, PhD
Senior Associate, 5AM Ventures

Derek Mazur, MSc
Private Company Investor, Cedar Pine

Rifat Pamukcu, MD
President & CEO, Midway Pharmaceuticals Inc.

Alyssa Panitch, PhD
Professor and Chair of the Wallace H. Coulter Department of Biomedical Engineering

Shyam Parekh, PhD, MBA
Parekh Advisory Services

Jay Parrish, PhD
Venture Partner, Arch Ventures

Preetha Ram, PhD
Sr. Managing Partner, Pier 70

Todd Sherer, PhD
Associate VP for Research Administration & Executive Director, Office of Technology Transfer, Emory University

Robert Taylor, MD
Professor of Medicine, Director, Division of Cardiology, Emory University School of Medicine

Robert Towarnicki, MS
Managing Partner, New Hope BioConsulting LLC and CEO, SIRPant Immunotherapeutics

David Wright, MD
Associate Professor and Director, Emergency Neurosciences at Emory University School of Medicine

Bob Yoder, MBA
Senior Vice President and Chief Business Officer, Trevena, Inc.